- For Patients
- Introduction to the Marshall Protocol
- Length of the MP
- Immunopathology
- Managing immunopathology
- Food and drink
- Light restriction
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Starting the Marshall Protocol
- Resources for patients
- Marshall Protocol summary
- Palliative vs. curative treatments
- Patient interviews on Bacteriality
- Non-MP treatments
- Glossary
- The Protocol
- Marshall Protocol summary
- Publications and presentations
- Science behind immunopathology
- Science behind olmesartan (Benicar)
- Safety of olmesartan
- Resources for physicians
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Physicians' concerns about the MP
- Notice for emergency medical personnel
- The Pathogenesis
- Publications and presentations
- Science behind Marshall Pathogenesis
- Microbes in the human body
- Successive infection and variability in disease
- Autoimmune theory of disease
- Science behind vitamin D
- Metabolism of vitamin D and the VDR
- Th1 Spectrum Disorder - how chronic inflammatory diseases are related
- Transmission of bacteria and onset of chronic disease
- Evolutionary perspective on disease
- Incidence and prevalence of disease
- Evidence that chronic disease is caused by pathogens
- Diseases
- Foundation
- Related Sites
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revision | Next revisionBoth sides next revision | ||
| home:social:support [01.05.2014] – [Starting a new support group] joyful | home:social:support [01.05.2014] – [Europe] add ugesa joyful | ||
|---|---|---|---|
| Line 32: | Line 32: | ||
| //There are currently no known MP support groups.// | //There are currently no known MP support groups.// | ||
| + | |||
| + | |||
| + | ==== Europe ==== | ||
| + | |||
| + | * ** Germany ** | ||
| + | * [[http:// | ||
| + | |||
| + | |||
| ==== United States ==== | ==== United States ==== | ||
| Line 40: | Line 48: | ||
| * **Arizona** | * **Arizona** | ||
| * contact: [[http:// | * contact: [[http:// | ||
| - | |||
| ===== Patients experiences ===== | ===== Patients experiences ===== | ||
home/social/support.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.